[Therapeutic dosage in half bridging?].
Emter
M
M
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D007431:Intraoperative Complications / Q000517:prevention & control; D013508:Ophthalmologic Surgical Procedures / Q000009:adverse effects* / Q000379:methods*; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin
D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin
Med Klin (Munich). 2007 Oct 15;102(10):809-15
17928964
Chest. 2008 Jun;133(6 Suppl):299S-339S
18574269